Roche
At a Glance
Roche, officially known as F. Hoffmann-La Roche AG, is a Swiss multinational healthcare company founded in 1896 and headquartered in Basel, Switzerland. As the world's largest biotechnology firm, Roche operates globally, providing innovative medicines and diagnostic solutions across major disease areas. The company is recognized as a leader in cancer treatments and is ranked as the fifth-largest pharmaceutical company by revenue. Roche operates through two main divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division focuses on developing breakthrough medicines in areas such as oncology, immunology, infectious diseases, and neuroscience. The Diagnostics division offers a comprehensive range of in-vitro diagnostic tools, including automated systems for blood and tissue analysis, as well as solutions for diabetes management. Roche also integrates digital health technologies to enhance patient care and personalize treatment. With a commitment to addressing healthcare challenges, Roche serves a diverse customer base, including hospitals, healthcare providers, and patients in over 100 countries.
Compiled from public job postings, careers pages, and company materials. Data may not reflect current state — verify during interviews.
Security Philosophy
Security Team
Key Initiatives
Security champions: Evidence Found. Jonathan Sinclair's public interview describes cybersecurity champions at various sites as helping bridge technical teams and business objectives; detailed program structure and ownership are not publicly available. Shift-left: Roche describes integrating security and testing throughout the SDLC, automated SAST/SCA/container-scanning guardrails in DevOps workflows, and a current SDET posting requiring automated SAST/DAST analysis. Vulnerability intake: Roche accepts reports from intrusion-protection and detection systems, industry information, employees, customers, and external actors; Diagnostics also accepts reports through security@roche.com. Triage and remediation: Roche states that confirmed findings are acknowledged, assigned a contact person, assessed for risk, assigned a CVE where applicable, and published; product teams analyze root cause and implement fixes or patches. Severity-based playbooks and coordinated communications are described. Secure-SDLC artifacts include threat modeling, risk assessments, penetration testing, vulnerability assessments, code-quality controls, dependency management, license compliance, IaC scanning, container-image scanning, API security, and runtime scanning. Recent public activity within six months includes the July 2026 Expert DevSecOps posting for software-security frameworks and automated guardrails, the August 2026 cybersecurity analyst posting for product vulnerability analysis using automation and AI, and the August 2026 SDET posting for shift-left SAST/DAST automation. These postings document responsibilities and requirements, not confirmed production rollouts. Company statements are
Preparing for an AppSec interview?
Get the weekly briefing 2,000+ security pros trust.
Interested in this role?
Apply on LinkedIn